These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2836769)

  • 41. Sex steroid receptors in gynecologic neoplasms.
    Carcangiu ML; Chambers JT
    Pathol Annu; 1992; 27 Pt 2():121-51. PubMed ID: 1584625
    [No Abstract]   [Full Text] [Related]  

  • 42. Circannual rhythms in steroid receptor concentration in gynecologic and breast cancers.
    Chambers JT; Lawrence R; MacLusky N; Eisenfield A; Schwartz PE
    Am J Obstet Gynecol; 1987 Mar; 156(3):728-9. PubMed ID: 3826223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms.
    Sakamoto H; Maclusky NJ; Schwartz PE; Naftolin F; Phil D; Den K; Takagi S
    Endocrinol Jpn; 1987 Apr; 34(2):179-87. PubMed ID: 3622387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
    Jänne O; Kauppila A; Syrjälä P; Vihko R
    Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evaluation of steroid receptors in ovarian neoplasms.
    Agarwal N; Rao DL; Murgeshan K; Verma U; Mittal S; Buckshee K; Chapeker TN
    Int J Gynaecol Obstet; 1987 Apr; 25(2):145-9. PubMed ID: 2884140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
    Kauppila A; Isotalo H; Kivinen S; Stenbäck F; Vihko R
    Int J Cancer; 1985 Feb; 35(2):157-63. PubMed ID: 3156097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen synthesizing rare malignant Brenner tumor of the ovary with the presence of progesterone and androgen receptors in the absence of estrogen receptors.
    Kühnel R; Rao BR; Stolk JG; van Kessel H; Seldenrijk CA; Willig AP
    Gynecol Oncol; 1987 Feb; 26(2):263-9. PubMed ID: 3804043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroid receptors in human ovarian malignancy. A review of four years tissue collection.
    Toppila M; Tyler JP; Fay R; Baird PJ; Crandon AJ; Eastman CJ; Hudson CN
    Br J Obstet Gynaecol; 1986 Sep; 93(9):986-92. PubMed ID: 3768292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone receptors in bilateral ovarian ependymoma presenting in pregnancy.
    Carr KA; Roberts JA; Frank TS
    Hum Pathol; 1992 Aug; 23(8):962-5. PubMed ID: 1644443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocrine factors in common epithelial ovarian cancer.
    Rao BR; Slotman BJ
    Endocr Rev; 1991 Feb; 12(1):14-26. PubMed ID: 1851084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.
    Grönroos M; Kangas L; Mäenpää J; Vanharanta R; Paul R
    Br J Obstet Gynaecol; 1984 May; 91(5):479-82. PubMed ID: 6232945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mouse ovarian tumor cells: an experimental model for progestin-mediated radiotherapy.
    Blumenthal RD; McLaughlin WH; Jordan JJ; Cryan EV; Bloomer WD
    J Surg Oncol; 1988 Oct; 39(2):96-100. PubMed ID: 3172797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hormone therapy in progressive and recurrent ovarian cancer].
    Jonat W
    Onkologie; 1985 Dec; 8(6):417-9. PubMed ID: 3912698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen, progesterone receptors in ovarian cancer.
    González ER
    JAMA; 1981 Apr; 245(16):1626. PubMed ID: 7206169
    [No Abstract]   [Full Text] [Related]  

  • 55. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy.
    Gloor E; Schnyder P; Cikes M; Hofstetter J; Cordey R; Burnier F; Knobel P
    Cancer; 1982 Nov; 50(9):1888-93. PubMed ID: 7116313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dynamic test of hormonal sensitivity of gynecologic malignancy by use of an antiestrogen, tamoxifen.
    Ozasa H; Noda Y; Mori T
    Am J Obstet Gynecol; 1988 May; 158(5):1120-3. PubMed ID: 3369494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen and progestin receptors in intracranial tumors.
    Punnonen R; Kuurne T
    Horm Res; 1987; 27(2):74-7. PubMed ID: 3653847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy.
    Nakano E; Tada Y; Fujioka H; Matsuda M; Osafune M; Kotake T; Sato B; Takaha M; Sonoda T
    J Urol; 1984 Aug; 132(2):240-5. PubMed ID: 6330380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
    Geisinger KR; Kute TE; Pettenati MJ; Welander CE; Dennard Y; Collins LA; Berens ME
    Cancer; 1989 Jan; 63(2):280-8. PubMed ID: 2910432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen and progestin receptors in colonic cancer?
    Wobbes T; Beex LV; Koenders AM
    Dis Colon Rectum; 1984 Sep; 27(9):591-2. PubMed ID: 6468198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.